Norspan-15h-Transderm-SE-BS-ING - UFIS-SWE-IG v0.1.0

UFIS-SWE-IG
0.1.0 - ci-build

UFIS-SWE-IG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/ufis-swe-ig/ and changes regularly. See the Directory of published versions

Example Ingredient: Norspan-15h-Transderm-SE-BS-ING

Generated Narrative: Ingredient Norspan-15h-Transderm-SE-BS-ING

status: Active

for:

MedicinalProductDefinition: identifier = http://ema.europa.eu/fhir/mpId#SE-100004434-00049408,http://ema.europa.eu/fhir/eurdId#459; domain = Human use; status = Current; combinedPharmaceuticalDoseForm = Transdermal patch; indication = Behandling av icke maligna smärtor av måttlig intensitet när en opioid krävs för att uppnå tillräcklig smärtlindring. Norspan är inte lämpligt för behandling av akuta smärttillstånd. Norspan är avsett för vuxna.; legalStatusOfSupply = Medicinal product subject to special medical prescription; classification = buprenorphine
ManufacturedItemDefinition: status = active; manufacturedDoseForm = Transdermal patch; unitOfPresentation = Patch
AdministrableProductDefinition: status = active; administrableDoseForm = Transdermal patch

role: Active

substance
Codes
- Concept
* Buprenorphine
strength
presentation: 15 microgram(s)/hour (Details: 100000110633 code100000166092 = '100000166092')/1 patch (Details: 200000000014 code200000002134 = '200000002134')
referenceStrength
Substances
- Concept
* Buprenorphine
strength: 15 microgram(s)/hour (Details: Unit of Measurement EMA code100000166092 = 'microgram(s)/hour')/1 patch (Details: 200000000014 code200000002134 = '200000002134')

Links: Table of Contents | QA Report

The UNICOM Innovation Action has received funding from the European Union's Horizon 2020
research and innovation programme under grant agreement No. 875299.